The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The initiative is focused on a problem that continues to plague cancer outcomes in India
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
At the trial’s pre-specified interim analysis, giredestrant achieved a hazard ratio of 0.70, marking a statistically significant improvement in invasive disease-free survival
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
Growing patent filings and tier-2 innovators reflect expanding national research base
Subscribe To Our Newsletter & Stay Updated
